| Literature DB >> 33358630 |
A A Alsultan1, A J A T Braat2, M L J Smits2, M W Barentsz2, R Bastiaannet3, R C G Bruijnen2, B de Keizer2, H W A M de Jong2, M G E H Lam2, M Maccauro4, C Chiesa4.
Abstract
Radioembolisation is a locoregional treatment modality for hepatic malignancies. It consists of several stages that are vital to its success, which include a pre-treatment angiographic simulation followed by nuclear medicine imaging, treatment activity choice, treatment procedure and post-treatment imaging. All these stages have seen much advancement over the past decade. Here we aim to provide an overview of the practice of radioembolisation, discuss the limitations of currently applied methods and explore promising developments.Entities:
Keywords: Hepatocellular carcinoma; PET; metastatic colorectal cancer; personalised dosimetry; radioembolisation
Year: 2020 PMID: 33358630 DOI: 10.1016/j.clon.2020.12.003
Source DB: PubMed Journal: Clin Oncol (R Coll Radiol) ISSN: 0936-6555 Impact factor: 4.126